Herpesviruses.
Bowers
M
M
San Francisco AIDS Foundation, San Francisco, CA.
D015075:2-Aminopurine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000212:Acyclovir / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D001086:Arabinofuranosyluracil / Q000031:analogs & derivatives / Q000627:therapeutic use; D000077404:Cidofovir; D000529:Complementary Therapies; D003596:Cytosine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000077595:Famciclovir; D017245:Foscarnet / Q000627:therapeutic use; D006566:Herpesviridae Infections / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000627:therapeutic use; D000077483:Valacyclovir; D014633:Valine / Q000031:analogs & derivatives / Q000627:therapeutic use; D014765:Viral Vaccines / Q000627:therapeutic use
D000998:Antiviral Agents; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D014765:Viral Vaccines; D001086:Arabinofuranosyluracil; D017245:Foscarnet; D015075:2-Aminopurine; D003596:Cytosine; C031368:sorivudine; D014633:Valine; D000077404:Cidofovir; D000077483:Valacyclovir; D000077595:Famciclovir; D000212:Acyclovir